Cancer survival statistics in China 2019-2021: a multicenter, population-based study.

ABSTRACT:

Background

A milestone goal of the Healthy China Program (2019-2030) is to achieve 5-year cancer survival at 43.3% for all cancers combined by 2022. To assess the progress towards this target, we analyzed the updated survival for all cancers combined and 25 specific cancer types in China from 2019 to 2021.

Methods

We conducted standardized data collection and quality control for cancer registries across 32 provincial-level regions in China, and included 6,410,940 newly diagnosed cancer patients from 281 cancer registries during 2008-2019, with follow-up data on vital status available until December 2021. We estimated the age-standardized 5-year relative survival overall and by site, age group, and period of diagnosis using the International Cancer Survival Standard Weights,

SUBMITTER: Zeng H 

PROVIDER: S-EPMC11401485 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature